// STATE LEGISLATION TRACKER

New York A10004 — CAPITAL PROJECTS BUDGET

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: New York
Bill: A10004
Filed: 2026-01-21
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

This appears to be a New York capital projects budget bill, based only on the provided title and subjects. Nothing provided suggests it changes peptide access, compounding rules, prescribing, telehealth, clinician scope, controlled substances, or prescription monitoring.

Key Points

No clear change to compounded peptide access is shown
No clear impact on off-label prescribing is shown
No telehealth or clinician scope change is indicated
No FDA 503A or 503B compounding change is indicated

What to Watch For

Note If full bill text becomes available, check for hidden health, pharmacy, or controlled-substance provisions.

Note Budget bills can contain unrelated policy language, but none is visible from the provided title and subjects.

Where the Bill Stands

The latest action is unavailable because the OpenStates refetch failed, so the bill's current procedural status cannot be confirmed from the provided data.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws